Policy Analysis: Investment, Life Sciences
Horizon 2020 Special Coverage
The 2015 Science|Business Annual Summit
The Science|Business Annual Summit brings together leaders from research, industry and policy to debate current and future trends needed to unleash Europe’s technological potential.
Barcelona - 17 November 2015
The future of manufacturing: Industry 4.0
A Science|Business public conference
Brussels - 01 October 2015
The Bioeconomy Challenge: Producing more from less
A Science|Business high-level roundtable
Brussels - 02 July 2015
The new European Commission: Bad news for research and innovation?
Advocates for cross-sectoral R&D support fear a downgrade in the new Commission – but in individual areas such as energy, digital technologies, and pharmaceuticals, a stronger emphasis on growth and investment is good news for many
Published:
Harmonise clinical trial regulations to boost medical research - and save lives

Complex and inconsistent clinical trial regulations are causing delays and raising costs for academic clinicians conducting international studies. Governments need to harmonise trial approval processes, says the OECD


Frédéric Sgard, Project Administrator, OECD Global Science Forum

Clinical trials are an essential part of the development of medical treatments. They involve  testing new medicines or new therapies, as well as optimising existing medicinal products and procedures, by carrying out carefully controlled investigations on patients. Although the majority of these trials are conducted by the pharmaceutical industry, many are driven by pressing public health needs, and by scientific opportunities, rather than by economic interests of private companies.

Such trials often involve diseases that affect...



Related subjects: clinical diagnostics

Advertisement